# Etanercept

## Enbrel 50mg prefilled pen

| TAH Drug Code      | [IENB5](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IENB5)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Adults with active rheumatoid arthritis inadequately responsive to DMARDs. Adults with moderate to severe active rheumatoid arthritis not previously treated with methotrexate. Children and adolescents over 2 years with active polyarticular juvenile idiopathic arthritis unresponsive or intolerant to methotrexate. Adults with active and progressive psoriatic arthritis inadequately responsive to DMARDs. Treatment of active ankylosing spondylitis. Adults with severe active non-radiographic axial spondyloarthritis (nr-axSpA) with all the following: Inadequate response or intolerance to NSAIDs. Elevated C-reactive protein (CRP). MRI evidence of inflammation. HLA-B27 positive. Adults with moderate to severe psoriasis unresponsive, contraindicated, or intolerant to other systemic therapies (cyclosporine, methotrexate, or PUVA). Children and adolescents over 6 years with severe psoriasis unresponsive or intolerant to systemic therapies or phototherapy. |
| Dosing             | SC, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, plaque psoriasis 50 mg once weekly or 25 mg twice weekly. Alternatively, plaque psoriasis 50 mg twice weekly for 12 weeks, then 50 mg once weekly or 25 mg twice weekly for 12 weeks.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Contraindications  | Contraindicated for individuals allergic to the active ingredient etanercept or any excipients, those with sepsis or at risk of sepsis, and patients with active infections (including chronic or localized infections).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Adverse Effects    | Common: Injection site disorder (Plaque psoriasis, 7-15%; rheumatoid arthritis, 37-43%), Upper respiratory infection (38-65%). Serious: Congestive heart failure, Erythema multiforme, Melanoma, Necrotizing fasciitis, Primary cutaneous vasculitis, Skin cancer, Squamous cell carcinoma of skin, Stevens-Johnson syndrome, Toxic epidermal necrolysis, Aplastic anemia (<0.01%), Leukemia, Pancytopenia (<0.1%), Reactivation of hepatitis B viral hepatitis (<0.01%), Autoimmune hepatitis (<0.1%), Cancer, Hepatosplenic T-cell lymphoma, Hypersensitivity reaction (<2%), Malignant lymphoma, Demyelinating disease of central nervous system, Multiple sclerosis, Peripheral demyelinating neuropathy, Seizure, Transverse myelitis, acute, Optic neuritis, Tuberculosis (0.006-0.02%), Infectious disease.                                                                                                                                                                            |
| Pregnancy          | Human Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| More Info          | [UpToDate](https://www.uptodate.com/contents/etanercept-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

